Owners Scott and Susan Hellervik open Tint World Louisville while planning two additional area locations for the National Automotive Styling Centers™ franchise LOUISVILLE, Ky., Dec. 13, 2023 /PRNewswire/ — Tint World® Automotive Styling Centers™, a leading auto accessory and window… Go to Source
Category: Newswire
Adalimumab (Humira) Biosimilars Pipeline Review 2023
DUBLIN, Dec. 14, 2023 /PRNewswire/ — The “Adalimumab (Humira) Biosimilars Pipeline Review” report has been added to ResearchAndMarkets.com’s offering. This product provides basic information on approved drugs and drug candidates in research and development as biosimilar antibodies of Humira (adalimumab). Adalimumab (drug code: LU-200134) was discovered by Knoll Pharmaceuticals, a subsidiary of BASF, using phage display technology… Continue reading Adalimumab (Humira) Biosimilars Pipeline Review 2023
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Blue Ridge Bankshares, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – BRBS
NEW YORK, Dec. 14, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Blue Ridge Bankshares, Inc. (NYSE American: BRBS) between March 10, 2023 and October 31, 2023, both dates inclusive (the “Class Period”), of the important February 5, 2024 lead plaintiff deadline in the securities… Continue reading ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Blue Ridge Bankshares, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – BRBS
Ranibizumab (Lucentis) Biosimilars Pipeline Review 2023: Information on Approved Drugs and Drug Candidates in Research and Development as Biosimilar Antibodies
DUBLIN, Dec. 14, 2023 /PRNewswire/ — The “Ranibizumab (Lucentis) Biosimilars Pipeline Review” report has been added to ResearchAndMarkets.com’s offering. This product provides basic information on approved drugs and drug candidates in research and development as biosimilar antibodies of Lucentis (ranibizumab). Lucentis (ranibizumab injection) is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment (Fab) designed for intraocular… Continue reading Ranibizumab (Lucentis) Biosimilars Pipeline Review 2023: Information on Approved Drugs and Drug Candidates in Research and Development as Biosimilar Antibodies
NEXCOM Empowering Future Networks with 5th Gen Intel Xeon Processors
TAIPEI, Dec. 14, 2023 /PRNewswire/ — NEXCOM, a leading supplier of network appliances, proudly unveils the NSA 7160R, the latest addition to its high-performance cybersecurity and networking product line. Powered by the revolutionary 5th Gen Intel Xeon scalable processor family and equipped with advanced technologies for security and AI application, this cutting-edge appliance guarantees unmatched… Continue reading NEXCOM Empowering Future Networks with 5th Gen Intel Xeon Processors
NEXCOM Empowering Future Networks with 5th Gen Intel Xeon Processors
TAIPEI, Dec. 15, 2023 /PRNewswire/ — NEXCOM, a leading supplier of network appliances, proudly unveils the NSA 7160R, the latest addition to its high-performance cybersecurity and networking product line. Powered by the revolutionary 5th Gen Intel Xeon scalable processor family and equipped with advanced technologies for security and AI application, this cutting-edge appliance guarantees unmatched… Continue reading NEXCOM Empowering Future Networks with 5th Gen Intel Xeon Processors
Statement from Aflac Incorporated and Trupanion Confirming Commitment to Strategic Alliance in North America
COLUMBUS, Ga. and SEATTLE, Dec. 14, 2023 /PRNewswire/ — “Since the establishment of a strategic business alliance in November 2020, Aflac Incorporated and Trupanion have shared a common belief that employers should consider a package of benefits for their employees to address the increasing number of consumers whose pets are a vital part of their families. Our collaboration addresses the… Continue reading Statement from Aflac Incorporated and Trupanion Confirming Commitment to Strategic Alliance in North America
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ChargePoint Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CHPT
NEW YORK, Dec. 14, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ChargePoint Holdings, Inc. (NYSE: CHPT) between June 1, 2023 and November 16, 2023, both dates inclusive (the “Class Period”), of the important January 29, 2024 lead plaintiff deadline. SO WHAT: If you purchased ChargePoint securities… Continue reading ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ChargePoint Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CHPT
Ustekinumab (Stelara) by Janssen Biotech Biosimilars Pipeline Review 2023: Information on Approved Drugs and Drug Candidates in Research and Development as Biosimilar Antibodies
DUBLIN , Dec. 14, 2023 /PRNewswire/ — The “Ustekinumab (Stelara) Biosimilars Pipeline Review” report has been added to ResearchAndMarkets.com’s offering. This product provides basic information on approved drugs and drug candidates in research and development as biosimilar antibodies of Stelara (ustekinumab). Developed by Janssen Biotech, the blockbuster therapeutic antibody STELARA (INN: ustekinumab) is an approved human interleukin-12 and interleukin-23… Continue reading Ustekinumab (Stelara) by Janssen Biotech Biosimilars Pipeline Review 2023: Information on Approved Drugs and Drug Candidates in Research and Development as Biosimilar Antibodies
DAISO NEW STORE OPENING IN STOCKTON, CALIFORNIA
STOCKTON, Calif., Dec. 14, 2023 /PRNewswire/ — Daiso, the renowned global retail chain offering a wide range of affordable and unique products, is thrilled to announce the grand opening at Sherwood Place in Stockton, California on December 30th. “We are thrilled to open our store at Sherwood Place,” said Jack Williams, Chief Retail Operations Officer for… Continue reading DAISO NEW STORE OPENING IN STOCKTON, CALIFORNIA